Treatment of Acute Pelvic Inflammatory Disease

Table 4

Clinical and microbiologic cure rates for pelvic inflammatory disease treatment regimens.

	Clinical cure			Microbiologic cure
Regimen	Number of studies	Number of patients	Percent	Number of studies	Number of patients	Percent
Parenteral
Clindamycin/aminoglycoside	11	470	92	8	143	97
Cefoxitin/doxycycline	9	836	95	7	581	96
Cefotetan/doxycycline	3	174	94	2	71	100
Ciprofloxacin	4	90	94	4	72	96
Ofloxacin	2	86	99	2	50	98
Sulbactam-ampicillin/doxycycline	1	37	95	1	33	100
Metronidazole/doxycycline	2	36	75	1	7	71
Azithromycin	1	30	100	1	30	100
Azithromycin/metronidazole	1	30	97	1	30	97
Oral
Ceftriaxone/probenecid/doxycycline	1	64	95	1	8	100
Cefoxitin/probenecid/doxycycline	3	212	90	3	71	93
Cefoxitin/doxycycline	4	634	94	4	493	95
Amoxicillin-clavulanic acid	2	35	100	2	35+	100
Ciprofloxacin/clindamycin	1	67	97	1	10	90
Ofloxacin	2	165	95	2	42+	100
Levofloxacin	1	41	85	1	9	89

Reprinted with permission from Walker and Sweet [64].